References
- Bartus R. T. Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine. Pharmacology, Biochemistry and Behavior 1978; 9: 833–836
- Bartus R. T. Physostigmine and recent memory: effects in young and aged nonhuman primates. Science 1979; 206: 1087–1089
- Caltagirone C., Gainotti G., Masullo C., Miceli G. Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatrica Scandinavica 1979; 60: 50–56
- Davis P., Maloney A. J. F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976; 2: 1403
- Davis K. L., Mohs R. C., Tinklenberg J. R., Pfefferbaum A., Hollister L. E., Kopell B. S. Physostigmine improvement of long term memory processes in normal humans. Science 1978; 201: 272–274
- Drachman D. A., Sahakian B. J. Memory and cognitive function in the elderly. A preliminary trial of physostigmine. Archives of Neurology 1980; 37: 674–675
- Gainotti G., Caltagirone C., Masullo C., Miceli G. Patterns of neuropsychologic impairment in various diagnostic groups of dementia. Aging of the brain and dementia (Aging 13), L. Amaducci, A. N. Davison, P. Antuono. Raven Press, New York 1980
- Glen A. I. N., Whalley L. J. Alzheimer's disease. Early recognition of potentially reversible deficits. Churchill Livingstone, Edinburgh 1979
- Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1976; 1: 189
- Zeisel S. M., Reinstein D. K., Wurtman R. J., Corkin S., Growdon J. H. Memory disorders associated with aging. Trends in Nueroscience 1981; 4: 8–9